Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Phathom Pharmaceuticals, Inc. (PHAT) had Income from Continuous Operations of $-201.59M for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$0.68M |
|
$-201.59M |
|
$0.17M |
|
$0.52M |
|
$167.99M |
|
$-167.31M |
|
$-34.28M |
|
$-201.59M |
|
$-201.59M |
|
$-201.59M |
|
|
Income from Continuous Operations |
$-201.59M |
$-201.59M |
|
$-201.59M |
|
$-167.31M |
|
$-164.86M |
|
51.29M |
|
51.29M |
|
$-3.93 |
|
$-3.93 |
|
| Balance Sheet Financials | |
$397.43M |
|
$2.15M |
|
$16.41M |
|
$413.84M |
|
$38.78M |
|
$137.84M |
|
$447.82M |
|
$486.60M |
|
$-72.76M |
|
$-72.76M |
|
$-72.76M |
|
57.97M |
|
| Cash Flow Statement Financials | |
$-137.58M |
|
$-1.63M |
|
$367.58M |
|
$155.89M |
|
$384.26M |
|
$228.37M |
|
$45.02M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.25 |
|
-- |
|
-- |
|
2.12 |
|
-1.89 |
|
75.51% |
|
-24532.55% |
|
-24532.55% |
|
-24173.02% |
|
-29558.95% |
|
-29558.95% |
|
$-139.21M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
0.14 |
|
0.42 |
|
876.11 |
|
277.07% |
|
277.07% |
|
-48.71% |
|
-309.75% |
|
$-1.26 |
|
$-2.71 |
|
$-2.68 |
|